Applications from students wishing to work flexibly or part-time are particularly encouraged
PhD applicants should have or expect to obtain a very good honours degree in Life Sciences. They should also be able to demonstrate an aptitude for experimental work and be highly committed to pursuing a career in cell and molecular biology related to cancer. We have an excellent reputation and track record in training its graduate students who go on to research positions throughout the world.
We will consider applications from self-funded students at anytime. Please contact your referred supervisor(s) in the first instance. Applicants will be expected to have or expect to obtain a very good honours degree in Life Sciences and must meet the University's English language requirments (http://www.gla.ac.uk/international/englishlanguagerequirements/).
Funded PhD scholarship opportunities
Paul O'Gorman Leukaemia Research Centre PhD Studentship
Friends of Paul O'Gorman funded PhD Studentships
Applications are invited from outstanding candidates to join a Cancer Research UK funded PhD programme at the Edinburgh Cancer Research Centre.
Details of the projects available to start in October 2022 can be found below - each project description includes a link that will direct you to the CRUK Beatson Institute recruitment page - please make your application there.
Dissecting the role of Activin signalling in Pancreatic Ductal Adenocarcinoma Professor Jennifer Morton, Dr Alan Serrels, Professor Gareth Inman
Development of cellular and tissue segmentation algorithms within the digital pathology platform QuPath for accurate assessment of mIF across a breadth of solid tumours Prof John Le Quesne, Dr Peter Bankhead, Prof Joanne Edwards
Elucidating the role of primary and secondary senescence in liver cancer Dr Kristina Kirschner, Dr Tom Bird, Prof Stuart Forbes
Understanding the pro- and anti-tumour functions of IFNγ-producing γδ T cells Dr Seth Coffelt and Dr Kevin Myant
Differential growth factor pathways in mesothelioma subtypes Prof Daniel J. Murphy and Dr Luke Boulter
Understanding the role of IKKα in the tumour microenvironment and establishing it as a novel therapeutic target in colorectal cancer Prof Joanne Edwards, Dr Lesley Stark, Dr Nigel Jamieson
Investigating the role of tertiary lymphoid structures in tumour-mediated immunosuppression in pancreaticobiliary cancer employing spatial biology characterisation Dr Nigel Jamieson, Dr Peter Bankhead, Prof John Le Quesne
Exploiting metabolic vulnerabilities induced by dietary restriction as novel therapies for infant leukaemia Prof Christina Halsey and Prof Katrin Ottersbach
The role of dynamic changes in proteome in pancreatic cancer initiation Dr Simon Wilkinson, Prof Jennifer Morton, Prof Sara Zanivan
Targeting Integrin Linked kinase (ILK) in Glioblastoma Prof Neil Carragher, Dr Joanna Birch, Prof Margaret Frame
Preclinical investigation of novel super-selective mTOR inhibitors in colorectal cancer Dr Asier Unciti-Broceta, Prof Owen Sansom, Prof Margaret Frame
A multimodal deep learning model to predict individual cancer patient survival probabilities Dr Peter Hall, Dr Colin McLean, Prof Joanne Edwards
Closing date: 27 May 2022
Interviews are expected to be held week beginning 27 June.
Developing a high throughput rectal cancer preclinical radiotherapy research platform to evaluate novel drug-radiotherapy combinations
Full details can be found here
For informal enquiries please conact: Dr Campbell Roxburgh
Application deadline: Tuesday 6th April 2021, 5pm